Skip to main content

Table 5 Test-retest reliability of the DIA-X-5 core (stem) items

From: Test-retest reliability of the computer-assisted DIA-X-5 interview for mental disorders

Stem Items for diagnosis (lifetime)

Cross-tabulation

T1

Jaccard Index (JI)

Agreement (%)

Cohen’s Kappa

no

yes

T2

no

.

.

Reversed JI

 

(CI of Kappa)

yes

.

.

Neurodevelopmental disorders

 Attention-deficit/ hyperactivity disorder

  

30

11

0.57

78.3

0.56

  

2

17

0.70

 

(0.35–0.76)

Schizophrenia spectrum and other psychotic disorders

 Possible psychotic disorder

  

24

6

0.83

90.0

0.80

  

0

30

0.80

 

(0.65–0.95)

Bipolar and related disorders

 Manic / hypomanic episode

  

29

11

0.55

76.7

0.52

  

3

17

0.67

 

(0.31–0.73)

Depressive disorders

 Major depressive disorders

  

17

4

0.91

93.3

0.85

  

0

39

0.81

 

(0.70–0.99)

 Persistent depressive disorder (dysthymia)

  

33

10

0.63

83.3

0.65

  

0

17

0.77

 

(0.47–0.84)

 Disruptive mood dysregulation disordera, b

  

51

2

0.44

91.7

0.57

  

3

4

0.91

 

(0.23–0.91)

Anxiety disorders

 Agoraphobia

  

46

5

0.64

91.7

0.73

  

0

9

0.90

 

(0.52–0.95)

 Social anxiety disorder

  

21

1

0.87

91.7

0.83

  

4

34

0.81

 

(0.68–0.97)

 Specific phobia

  

40

2

0.80

93.3

0.84

  

2

16

0.91

 

(0.69–0.99)

 Panic disorder

  

31

5

0.76

88.3

0.76

  

2

22

0.82

 

(0.60–0.93)

 Generalized anxiety disorder

  

30

3

0.87

93.3

0.87

  

1

26

0.88

 

(0.74–0.99)

 Separation anxiety disorder b

  

48

6

0.33

86.7

0.43

  

2

4

0.86

 

(0.11–0.75)

Obsessive-compulsive and related disorders

 Obsessive-compulsive disorder

  

30

3

0.87

93.3

0.87

  

1

26

0.88

 

(0.74–0.99)

Trauma- and stress-related disorders

 Post-traumatic stress disorder (PTSD) / Acute stress disorder

  

24

3

0.78

86.7

0.73

  

5

28

0.75

 

(0.56–0.90)

 Adjustment disorder

  

16

4

0.82

86.7

0.70

  

4

36

0.67

 

(0.51–0.89)

Somatic symptom and related disorders

 Somatic symptom disorder

  

11

3

0.90

91.7

0.76

  

2

44

0.69

 

(0.56–0.96)

 Illness anxiety disorder

  

40

4

0.75

91.7

0.80

  

1

15

0.89

 

(0.63–0.97)

Eating disorders

 Weight loss stem item

  

18

6

0.81

86.7

0.71

  

2

34

0.69

 

(0.53–0.90)

 Binge eating stem item

  

47

2

0.77

95.0

0.84

  

1

10

0.94

 

(0.66–1.00)

Disruptive, impulse-control, and conduct disorders

 Intermittent explosive disorder

  

43

5

0.71

91.7

0.77

  

0

12

0.90

 

(0.59–0.96)

 Conduct or antisocial personality disorder

  

45

3

0.80

95.0

0.86

  

0

12

0.94

 

(0.70–1.00)

 Oppositional defiant disorder

  

41

6

0.53

85.0

0.59

  

3

10

0.82

 

(0.35–0.83)

Substance-related and addictive disorders

 Alcohol use disorder – consume stem item

  

15

1

0.87

90.0

0.76

  

5

39

0.71

 

(0.59–0.94)

 Alcohol use disorder – symptom stem item

  

40

2

0.70

90.0

0.75

  

4

14

0.87

 

(0.57–0.94)

 Medication use – consume stem item

  

29

7

0.48

73.3

0.44

  

9

15

0.64

 

(0.20–0.67)

 Any drug use disorder – illicit drug consume stem question

  

43

0

0.94

98.3

0.96

  

1

16

0.98

 

(0.88–1.00)

 Any drug use disorder – symptom stem item

  

44

6

0.50

86.7

0.59

  

2

8

0.85

 

(0.33–0.84)

 Tobacco use disorder – smoking stem item

  

35

3

0.88

95.0

0.90

  

0

22

0.92

 

(0.78–1.00)

 Tobacco use disorder – symptom stem item

  

42

2

0.89

96.7

0.92

  

0

16

0.95

 

(0.81–1.00)

  1. aPartly assessed by embedded questionnaires
  2. bsuggested criteria of at least ten positive cases is not fulfilled [19]
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us